HistoSonics Acquired in $2.25B Deal Led by K5 Global

Deal News | Aug 07, 2025 | Orrick, Herrington & Sutcliffe

HistoSonics Acquired in $2.25B Deal Led by K5 Global

HistoSonics, the company behind the Edison Histotripsy System, has announced a significant transaction which sees a majority stake in the company acquired by K5 Global. The deal also involves other prominent investors, including Bezos Expeditions and Wellington Management, valuing HistoSonics at around $2.25 billion. This acquisition is expected to expedite the global expansion of HistoSonics' innovative tumor therapy platform and represents a strategic move by K5 Global in the healthcare and biotechnology sectors. Orrick, Herrington & Sutcliffe played a pivotal advisory role, led by partners Max Cantor, Spencer Cohen, and Matthew Gemello. The transaction aligns with Orrick's strong presence in the global M&A market, where they have ranked among the top five firms globally.

Sectors

  • Healthcare
  • Biotechnology
  • Private Equity
  • Legal Advisory

Geography

  • United States – The primary companies and advisors involved, such as K5 Global and Orrick, are based in the United States.

Industry

  • Healthcare – HistoSonics' operations focus on non-invasive tumor therapy, which falls under the healthcare sector.
  • Biotechnology – HistoSonics develops the Edison Histotripsy System, a novel therapy platform, which is a part of the biotechnology industry.
  • Private Equity – K5 Global's acquisition of HistoSonics reflects activities in the private equity sector.
  • Legal Advisory – Orrick, Herrington & Sutcliffe provided legal advisory services for the M&A transaction.

Financials

  • $2.25 Billion – The acquisition deal values HistoSonics at approximately $2.25 billion.

Participants

NameRoleTypeDescription
HistoSonicsTargetCompanyA company developing the Edison Histotripsy System, focusing on non-invasive tumor therapies.
K5 GlobalBidding CompanyCompanyA private equity firm leading the acquisition of a majority stake in HistoSonics.
Bezos ExpeditionsInvestorCompanyPart of the syndicate of global investors acquiring HistoSonics.
Wellington ManagementInvestorCompanyA global investment management firm participating in the acquisition of HistoSonics.
Orrick, Herrington & SutcliffeLegal AdvisorCompanyA law firm providing legal advisory services for the acquisition deal.